Back from the brink: Sheila Lewis - Insights
Mayo Clinic Laboratories’ comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from autoimmune encephalitis.
Forging ahead after years of hardship: Anya Magnuson - Insights
At just 24-years-old Anya Magnuson has survived not just one but two close encounters with death. Focused, determined, and intent on experiencing life to its fullest, Anya never gave up. Nor did the multidisciplinary Mayo Clinic care team...
New tests launched in December - Insights
December 2021, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Stiff-Person/PERM Evaluation - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' stiff-person assay provides comprehensive evaluation for individuals on the spectrum of stiff-person syndrome. In addition to guiding treatment decisions, the assay...
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
Mayo Clinic Laboratory and pathology research roundup: July 19 - Insights
This week's research roundup features: Structural Cardiac Abnormalities in Patients with Atrial Fibrillation-Flutter and Myocardial Injury.
Mayo Clinic Laboratory and pathology research: May 3 - Insights
Featured abstract: An overview of the clinical presentation, pathology, and the current therapeutic approach of the main representative disorders in the spectrum of glomerulonephritis.
Mayo Clinic Laboratory and pathology research roundup: April 26 - Insights
Top highlights include: Arrhythmia variant associations and reclassifications in the eMERGE-III sequencing study.
Mayo Clinic Laboratory and pathology research roundup: May 17 - Insights
Top highlights include: Rapid exclusion of acute myocardial injury and infarction with a high sensitivity cardiac troponin T in the emergency department.
Mayo Clinic Laboratory and pathology research roundup: May 10 - Insights
Top highlights include: Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.